Evidence map›Paper›PMID 42477825›Full record

ArticleActa neuropathologica communications2026

Correction: A rare missense variant impacting NEK1 kinase function is associated with ALS.

David Brenner, Anna Ponomarenko, Iris Petrut, Sofia Beyrle, Matilde Contardo, Isabel Loss, Constantin Radke, Jonas Frank, Eleni Zimmer, Matthias Schlesner and 21 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta neuropathologica communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors.

David BrennerDepartment of Neurology, University Hospital Ulm, 89081, Ulm, Germany. david.brenner@uni-ulm.de.
Anna PonomarenkoInstitute of Anatomy and Cell Biology, Ulm University School of Medicine, Ulm, 89081, Germany.
Iris PetrutInstitute of Anatomy and Cell Biology, Ulm University School of Medicine, Ulm, 89081, Germany.
Sofia BeyrleInstitute of Anatomy and Cell Biology, Ulm University School of Medicine, Ulm, 89081, Germany.
Matilde ContardoDepartment of Neurosciences, Laboratory of Neurobiology and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, Leuven, 3000, Belgium.
Isabel LossDepartment of Neurology, University Hospital Ulm, 89081, Ulm, Germany.
Constantin RadkeInstitute of Neuropathology, RWTH Aachen University Hospital, Pauwelsstrasse 30, Aachen, 52074, Germany.
Jonas FrankBiomedical Informatics, Data Mining and Data Analytics, University of Augsburg, Augsburg, 86159, Germany.
Eleni ZimmerInstitute of Molecular Oncology and Stem Cell Biology (IMOS), Ulm University Hospital, Ulm, 89081, Germany.
Matthias SchlesnerBiomedical Informatics, Data Mining and Data Analytics, University of Augsburg, Augsburg, 86159, Germany.
Pascal AchenbachInstitute of Neuropathology, RWTH Aachen University Hospital, Pauwelsstrasse 30, Aachen, 52074, Germany.
Wendy ScheveneelsDepartment of Neurosciences, Laboratory of Neurobiology and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, Leuven, 3000, Belgium.
Amr AlyInstitute of Anatomy and Cell Biology, Ulm University School of Medicine, Ulm, 89081, Germany.
Hülya NazlicanDepartment of Neurology, Centre for ALS and Other Motor Neuron Disorders, Alfried Krupp Krankenhaus Rüttenscheid, Essen, 45131, Germany.
Jasper Hesebeck-BrinkmannDepartment of Neurology, University Hospital Ulm, 89081, Ulm, Germany.
Patrick OecklDepartment of Neurology, University Hospital Ulm, 89081, Ulm, Germany.
Kathrin MüllerInstitute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
Reiner SiebertCenter for Rare Diseases (ZSE) Ulm, Ulm University Hospital Center for Rare Diseases, Ulm, 89081, Germany.
Tobias BöckersGerman Center for Neurodegenerative Diseases (DZNE), Ulm site, Ulm, 89081, Germany.
Kristel van EijkDepartment of Neurology, Brain Centre Rudolf Magnus, University Medical Centre Utrecht, Utrecht University, Utrecht, 3584 CG, The Netherlands.
Jan VeldinkDepartment of Neurology, Brain Centre Rudolf Magnus, University Medical Centre Utrecht, Utrecht University, Utrecht, 3584 CG, The Netherlands.
Alexander KlegerCenter for Rare Diseases (ZSE) Ulm, Ulm University Hospital Center for Rare Diseases, Ulm, 89081, Germany.
Medhanie MulawMedical Faculty, Unit for Single-Cell Genomics, Ulm University, Ulm, 89081, Germany.
Peter M AndersenDepartment of Clinical Sciences, Neurosciences, Umeå University , Umeå, Sweden.
Karin ForsbergDepartment of Clinical Sciences, Neurosciences, Umeå University , Umeå, Sweden.
Jochen H WeishauptDepartment of Neurology, University Hospital Ulm, 89081, Ulm, Germany.
Seyed Babak LoghmaniDepartment of Neurology, University Hospital Ulm, 89081, Ulm, Germany.
Thorsten GrehlDepartment of Neurology, Centre for ALS and Other Motor Neuron Disorders, Alfried Krupp Krankenhaus Rüttenscheid, Essen, 45131, Germany.
Philip van DammeDepartment of Neurosciences, Laboratory of Neurobiology and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, Leuven, 3000, Belgium.
Joachim WeisInstitute of Neuropathology, RWTH Aachen University Hospital, Pauwelsstrasse 30, Aachen, 52074, Germany.
Alberto CataneseGerman Center for Neurodegenerative Diseases (DZNE), Ulm site, Ulm, 89081, Germany. acatanese@ukaachen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42477825
PMCPMC13386804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.